IP Library Granted Patent US 11,529,453
Granted Patent B2
US 11,529,453 · App. 16/206,560 · Granted Dec 20, 2022

Reduced-pressure treatment and debridement systems and methods

Inventors: Christopher Brian Locke (Bournemouth, GB); Timothy Mark Robinson (Shillingstone, GB); Amy K. McNulty (Stillwater, MN)
Assignee: KCI Licensing, Inc.
A61M1/90A61M1/3687A61M1/74A61M27/00Y10T137/0402
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,529,453
App. No.
16/206,560
Granted
Dec 20, 2022
Kind
B2
Abstract

A reduced-pressure treatment system for debriding a treatment area of a tissue site and applying reduced pressure is disclosed. The reduced-pressure treatment system includes a hydrogel having a blocked acid debriding agent. The hydrogel is adapted to cover the treatment area and enhance autolytic debridement at the treatment area. The reduced-pressure treatment system includes a manifold that is adapted to cover the hydrogel and distribute reduced pressure to the tissue site. The reduce-pressure treatment system also includes a sealing drape for forming a fluid seal over the tissue site and manifold. Other systems, methods, and dressings are presented.

Claims (13)

1. A reduced-pressure treatment system for debriding a treatment area of a tissue site, the system comprising:

a porous hydrophilic foam adapted to cover the treatment area;

a blocked acid debriding agent applied to the porous hydrophilic foam, wherein the blocked acid debriding agent comprises an alpha hydroxy acid and a blocking material;

a manifold adapted to cover the porous hydrophilic foam and distribute reduced pressure to the tissue site; and

a sealing drape for placing over the tissue site and manifold, the sealing drape adapted to form a fluid seal over the tissue site and manifold.

2. The reduced-pressure treatment system of claim 1 , further comprising a reduced-pressure interface for delivering reduced pressure to the manifold.

3. The reduced-pressure treatment system of claim 1 , wherein the blocked acid debriding agent comprises lactic acid and an arginine group.

4. The reduced-pressure treatment system of claim 1 , wherein the blocked acid debriding agent comprises glycolic acid and arginine.

5. The reduced-pressure treatment system of claim 1 , wherein the porous hydrophilic foam is adapted to soften and break apart over time in response to exposure to wound fluid.

6. The reduced-pressure treatment system of claim 5 , wherein the manifold is adapted to absorb the porous hydrophilic foam after the porous hydrophilic foam softens.

7. The reduced-pressure treatment system of claim 1 , wherein the manifold is adapted to absorb debrided necrotic tissue.

8. The reduced-pressure treatment system of claim 1 , wherein the porous hydrophilic foam is a preformed sheet.

9. The reduced-pressure treatment system of claim 1 , further comprising an intermediate foam layer between the porous hydrophilic foam and the manifold.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066445/0336 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064718/0544 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2022
From: MCNULTY, AMY K.; LOCKE, CHRISTOPHER B.; ROBINSON, TIMOTHY M.
To: KCI LICENSING, INC.
Reel/Frame 061534/0740 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2020
From: LOCKE, CHRISTOPHER BRIAN; ROBINSON, TIMOTHY MARK; MCNULTY, AMY K.
To: KCI LICENSING, INC.
Reel/Frame 052462/0325 →
Continuity (3)
Continuation 13588747 · Aug 17, 2012
Provisional Application 61529510 · Aug 31, 2011
Related Publication 20190192749A1 · Jun 27, 2019